Vivo Capital overview
Stories about Vivo Capital
Fubon Life approves $129m in commitments
The Taiwan-based insurance company has backed two private equity funds.
Vivo Capital raises $1.43bn
The Palo Alto-based private equity firm closed its ninth healthcare and life sciences fund above its target.
Vivo Capital contact information
Offices
192 Lytton Avenue, Palo Alto, 94301, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Dr. Gaurav Aggarwal | Job titleManaging Partner and Chief Investment Officer, Opportunity Fund | LocationPalo Alto, United States | Email  -------- |
| Key ContactMs. Jane Gong | Job titlePrincipal, Investor Relations | LocationBeijing, China | Email ----------- |
| Key ContactMs. Chloe Zhang | Job titlePrincipal, Investor Relations | LocationPalo Alto, United States | Email ----------- |
| Ms. Cinthia Sheu | Job titlePartner and Chief Operating Officer | LocationPalo Alto, United States | Email ----------- |
Vivo Capital funds managed
Funds in market: 2
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size ----------- | Open dateAug 2026 | Strategy ---------- | |
Fund size -------- | Open dateJul 2024 | Strategy ------ | |
Closed funds: 11
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ---------- | Close dateDec 2023 | Strategy --------- | |
Fund size -------- | Close dateApr 2022 | Strategy ----- | |
Fund size -------- | Close dateOct 2019 | Strategy ------ | |
Stories that mention Vivo Capital
A new prescription for US healthcare
Under the second Trump administration, policy change and regulatory scrutiny are steering healthcare investors’ attention towards a different set of opportunities.